Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

As expected, there were significant differences between the Vitamin D3 and FGF23 levels in patients with CKD as compared to healthy donors (Fig. 1b), 22.3 ng/mL vs 28.9 ng/mL and 485.6 pg/mL vs 39.4 pg/mL (P < 5 × 10− 4), respectively.

Source: Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Based on clinical diagnostic criteria, patients were stratified by clinical comorbidities including Type 2 Diabetes (fasting glucose level ≥ 121 mg/dL) and Hypertension (systolic BP ≥ 130 mmHg and diastolic BP ≥ 85 mmHg).

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Assessing known chronic kidney disease associated genetic variants in Saudi Arabian populations

Study design awaiting verification · BMC Nephrology · 2018

Original publication title

Assessing known chronic kidney disease associated genetic variants in Saudi Arabian populations

Cyril Cyrus; Samir Al-Mueilo; Chittibabu Vatte; Shahanas Chathoth; Yun R. Li; Hatem Qutub; Rudaynah Al Ali; Fahad Al-Muhanna; Matthew B. Lanktree; Khaled Riyad Alkharsah; Abdullah Al-Rubaish; Brian Kim-Mozeleski; Brendan Keating; Amein Al Ali

© The Author(s). 2018

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

CKD risk variants identified in European populations are present in Saudis. We did not find evidence to suggest heterogeneity of effect size compared to previously published estimates in European populations. Multivariable logistic regression analysis showed a statistically significant improvement in predicting the CKD using models with either FGF23 and vitamin D or FGF23, vitamin D level, and MYH9 genotypes (AUC = 0.93, 95% CI 0.90 to 0.95, P <  0.0001).

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Genome wide association studies of patients with European descent have identified common variants associated with risk of reduced estimated glomerular filtration rate (eGFR). A panel of eight variants were selected to evaluate their association and prevalence in a Saudi Arabian patient cohort with chronic kidney disease (CKD).

Source: Background

Abstract: What methods does the paper describe?

Eight genetic variants in four genes (SHROOM3, MYH9, SLC7A9, and CST3) were genotyped in 160 CKD patients and 189 ethnicity-matched healthy controls. Genetic variants were tested for association with the development of CKD (eGFR < 60 ml/min/1.73m2) and effects were compared with results obtained from 133,413 participants in the CKD genetics consortium. Multivariable regression was used to evaluate the role of these eight variants in improving prediction of CKD development.

Source: Methods

Abstract: Electronic supplementary material

The online version of this article (10.1186/s12882-018-0890-9) contains supplementary material, which is available to authorized users.

Source: Electronic supplementary material

Abstract: Results

All eight variants were present in Saudi populations with minor allele frequency ranging from 16 to 46%. The risk variant in all four genes demonstrated the same direction of effect as observed in European populations. One variant, rs4821480, in MYH9 was significantly associated with increased risk of development of CKD (OR = 1.69, 95% CI 1.22 to 2.36, P = 0.002), but the additional variants were not statistically significant given our modest sample size.

Source: Results

Abstract: Conclusions

CKD risk variants identified in European populations are present in Saudis. We did not find evidence to suggest heterogeneity of effect size compared to previously published estimates in European populations. Multivariable logistic regression analysis showed a statistically significant improvement in predicting the CKD using models with either FGF23 and vitamin D or FGF23, vitamin D level, and MYH9 genotypes (AUC = 0.93, 95% CI 0.90 to 0.95, P <  0.0001).

Source: Conclusions
Authors’ abstract

Background

Genome wide association studies of patients with European descent have identified common variants associated with risk of reduced estimated glomerular filtration rate (eGFR). A panel of eight variants were selected to evaluate their association and prevalence in a Saudi Arabian patient cohort with chronic kidney disease (CKD).

Methods

Eight genetic variants in four genes (SHROOM3, MYH9, SLC7A9, and CST3) were genotyped in 160 CKD patients and 189 ethnicity-matched healthy controls. Genetic variants were tested for association with the development of CKD (eGFR < 60 ml/min/1.73m2) and effects were compared with results obtained from 133,413 participants in the CKD genetics consortium. Multivariable regression was used to evaluate the role of these eight variants in improving prediction of CKD development.

Results

All eight variants were present in Saudi populations with minor allele frequency ranging from 16 to 46%. The risk variant in all four genes demonstrated the same direction of effect as observed in European populations. One variant, rs4821480, in MYH9 was significantly associated with increased risk of development of CKD (OR = 1.69, 95% CI 1.22 to 2.36, P = 0.002), but the additional variants were not statistically significant given our modest sample size.

Conclusions

CKD risk variants identified in European populations are present in Saudis. We did not find evidence to suggest heterogeneity of effect size compared to previously published estimates in European populations. Multivariable logistic regression analysis showed a statistically significant improvement in predicting the CKD using models with either FGF23 and vitamin D or FGF23, vitamin D level, and MYH9 genotypes (AUC = 0.93, 95% CI 0.90 to 0.95, P <  0.0001).

Electronic supplementary material

The online version of this article (10.1186/s12882-018-0890-9) contains supplementary material, which is available to authorized users.

Publication and source details

Original title: Assessing known chronic kidney disease associated genetic variants in Saudi Arabian populations

Cyril Cyrus; Samir Al-Mueilo; Chittibabu Vatte; Shahanas Chathoth; Yun R. Li; Hatem Qutub; Rudaynah Al Ali; Fahad Al-Muhanna; Matthew B. Lanktree; Khaled Riyad Alkharsah; Abdullah Al-Rubaish; Brian Kim-Mozeleski; Brendan Keating; Amein Al Ali

BMC Nephrology · 2018

© The Author(s). 2018https://creativecommons.org/licenses/by/4.0/Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.Deanship of Scientific Research, University of Dammam (SA)2014115Cyrus Cyril

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T21:49:50.290893+00:00

DOI: 10.1186/s12882-018-0890-9 · PMC5905143